National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn
These nationally agreed clinical guidelines are intended to support a range of health care workers who care for women with drug and alcohol use issues, and their infants and families. They have been developed through a process based on evidence reviews and expert consensus. The drugs covered include: opioids, alcohol, tobacco, cannabis, amphetamines, cocaine, benzodiazepines, inhalants.
Other topics covered are: breastfeeding, vertical transmission of blood-borne viruses, psychosocial aspects, obstetric implications, pain management in labour and early childhood development. Aboriginal and Torres Strait Islander issues are also addressed.
File link: National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn
- National Drug Strategy Publications
- Background Papers to the National Clinical Guidelines for the management of drug use during pregnancy, birth and the early development years of the newborn